AMGEN at American Oncology

Amgen is proud to be a part of the WCLC 2021. While you’re here, you can explore the latest scientific information and disease state education. Additionally, you can learn about Amgen’s long-term commitment to developing and delivering innovative medicines for oncology patients.

Click here to learn
more about Amgen Data

From disease state education to breaking news on clinical trials, Amgen is making an impact on the oncology landscape.